Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Refractory Non-Hodgkin Lymphomas
.
Show all posts
Showing posts with label
Refractory Non-Hodgkin Lymphomas
.
Show all posts
Tuesday, December 28, 2021
Incyte Announces Acceptance of NDA for Parsaclisib for Refractory Non-Hodgkin Lymphomas
›
Incyte (Nasdaq:INCY) announced, that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for par...
›
Home
View web version
